APP and amyloidosis: Metabolomic results from APP/PS1 mouse models revealed that the liver was the organ first affected during the progression of amyloid pathology, demonstrating impaired energy metabolism, amino acid metabolism, nucleic acid metabolism, as well as ketone and fatty acid metabolism (Zheng et al. 2019).